---
title: "Peripheral Artery Disease (PAD) Clinical Trials | Amavita Research"
url: https://md.amavitaresearch.com/therapeutic-areas/peripheral-artery-disease
canonical: https://www.amavitaresearch.com/therapeutic-areas/peripheral-artery-disease
schema_type: MedicalCondition
last_updated: 2026-05-13
---

# Peripheral Artery Disease Clinical Trials

Amavita Research enrolls patients into peripheral artery disease (PAD) clinical trials, with Dr. Pedro Martinez-Clark serving as Principal Investigator on peripheral atherectomy protocols.

## Currently enrolling

- **GREAT (Golazo® atherectomy)** — Avantec/CSI, Phase 3 PAD. PI: Pedro Martinez-Clark, MD, FACC. https://www.amavitaresearch.com/trials/golazo-great

## Patient profile

- Intermittent claudication (Rutherford 2–4)
- Critical limb ischemia (Rutherford 5–6)
- Below-the-knee disease
- ABI/TBI documented disease
- Diabetes with PAD (high prevalence in Miami population)

## What patients can expect

Free trial-related care, including study procedures performed at the affiliated Advanced Cardiovascular of Miami ambulatory surgical center. PI is a Harvard-trained interventional cardiologist with extensive peripheral atherectomy experience.

## Sponsor decision criteria

- Active interventional PI with below-the-knee atherectomy experience
- Direct cath-lab access via Advanced Cardiovascular of Miami
- IVUS/OCT available for endpoint imaging
- Multilingual patient population includes high-prevalence diabetic PAD cohort

## Key links

- GREAT trial detail: https://www.amavitaresearch.com/trials/golazo-great
- Dr. Pedro Martinez-Clark profile: https://www.amavitaresearch.com/team/pedro-martinez-clark
- Patient guide: https://www.amavitaresearch.com/blog/peripheral-artery-disease-clinical-trials-patient-guide
- Site capabilities: https://www.amavitaresearch.com/capabilities
- Contact: https://www.amavitaresearch.com/contact-patient